Alessandro Martino
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium.
Journal: Leukemia & lymphoma
Published: November 21, 2019
Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.
Journal: Nature communications
Published: December 10, 2015
Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.
Journal: Nature communications
Published: September 18, 2014
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length.
Journal: International journal of cancer
Published: May 14, 2014
Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: February 14, 2014
Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium.
Journal: Journal of human genetics
Published: January 11, 2013
Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma.
Journal: British journal of haematology
Published: July 25, 2012
Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium.
Journal: British journal of haematology
Published: May 17, 2012
Last Updated: 09/26/2026